Stem Cells Market Scope
The stem cell is used for treating chronic diseases such as cardiovascular disorders, cancer, diabetes, and others. Growing research and development in stem cell isolation techniques propelling market growth. For instance, a surgeon from Turkey developed a method for obtaining stem cells from the human body without enzymes which are generally used for the isolation of stem cells. Further, growing healthcare infrastructure in the developing economies and government spending on the life science research and development expected to drive the demand for stem cell market over the forecasted period.
The market study is being classified by Type (Adult Stem Cells [Neuronal, Hematopoietic, Mesenchymal, Umbilical Cord, Others], Human Embryonic Stem Cells (hESC), Induced Pluripotent Stem Cells and Very Small Embryonic-Like Stem Cells), by Application (Regenerative Medicine [Neurology, Orthopedics, Oncology, Hematology, Cardiovascular and Myocardial Infraction, Injuries, Diabetes, Liver Disorder, Incontinence, Others] and Drug Discovery and Development) and major geographies with country level break-up.
Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Stem Cells market throughout the predicted period.
Smith & Nephew (United Kingdom), Celgene Corporation (United States), BIOTIME, INC. (United States), Cynata (Australia), Applied Cell Technology (Hungary), STEMCELL Technologies Inc. (Canada), BioTime Inc. (United States), Cytori Therapeutics, Inc. (United States), Astellas Pharma Inc. (Japan), U.S. Stem Cell, Inc. (United States) and Takara Holdings. (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Caladrius Biosciences, Inc. (United States), Cellular Engineering Technologies Inc. (United States) and BrainStorm Cell Therapeutics Inc. (United States).
AdvanceMarketAnalytics has segmented the market of Global Stem Cells market by Type, Application and Region.
On the basis of geography, the market of Stem Cells has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology , the sub-segment i.e. Cell Acquisition [Bone Marrow Harvest, Umbilical Blood Cord, Apheresis] will boost the Stem Cells market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Therapy , the sub-segment i.e. Autologous will boost the Stem Cells market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
“The Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) regulates human cells, tissues, and cellular and tissue-based products (HCT/P) intended for implantation, transplantation, infusion or transfer into a human recipient, including hematopoietic stem cells. Stem cells come from different sources and are used in a variety of procedures or applications. Stem cells from bone marrow, umbilical cord blood or peripheral blood are routinely used in transplantation procedures to treat patients with cancer and other disorders of the blood and immune system. Stem cells sourced from cord blood for unrelated allogeneic use also are regulated by the FDA, and a license is required for distribution of these products.”
- Emphasizing On Development of Regenerative Medicine
- Technological Advancement in Stem Cell Harvesting and Isolation Techniques
- Rising Prevalence of Chronic Diseases such as Cardiovascular Disorders, Cancer, and others
- Growing Healthcare Infrastructure in the Developing Economies
- Growing Demand for Cellular Therapies
- Rising Application of Autologous Therapy
- Stringent Government Regulations Regarding Stem Cells
- Lack of Skilled Professionals
- Lack of Awareness Regarding Stem Cell Therapy in the Low and Middle Income Group Countries
Key Target AudienceHealthcare Institution, Contract Research Manufacturers, Associations, Organizations, Forums, and Alliances, Government Bodies and Departments, Research Institutes and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase